EUVIMEDEUVIMED entdecken
Crossref

Relationships between postoperative recurrences and standardized uptake value on 18F-fluorodeoxyglucose-positron emission tomography in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma who underwent curative pancreatic resection after neoadjuvant chemoradiotherapy

Hironobu Suto, Mina Nagao, Hiroyuki Matsukawa, Takuro Fuke, Yasuhisa Ando, Minoru Oshima, Shigeo Takahashi, Toru Shibata, Hideki Kamada, Hideki Kobara, Hiroyuki Okuyama, Tomohiro Hirao und 2 weitere

Pancreatology · 2024

DOI: 10.1016/j.pan.2024.08.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2024. Verfasst von Hironobu Suto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan. Electronic address: suto.hironobu@kagawa-u.ac.jp. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Positron-Emission Tomography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: This study aimed to examine postoperative recurrence after curative pancreatic resection following neoadjuvant chemoradiotherapy (NACRT) in patients with resectable (R-) and borderline resectable (BR-) pancreatic ductal adenocarcinoma (PDAC), focusing on its relationship with the standardized uptake value (SUV) on 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET). METHOD: The postoperative initial recurrence patterns were examined in patients with R- and BR-PDAC who underwent NACRT followed by curative pancreatic resection. Data collected from three prospective clinical trials were retrospectively analysed. RESULTS: After a median follow-up of 29 months, 91 (60 %) of 151 patients experienced postoperative recurrence. The median recurrence-free survival (RFS) for all patients was 18 months. The sites of first recurrence were lung-only in 24 (26 %) patients, liver-only in 23 (25 %), local-only in 11 (12 %), peritoneum-only in 10 (11 %), other single site in 5 (5 %), and multiple sites in 19 (21 %) patients. Multivariate analysis identified the maximum standardized uptake value (SUVmax) on FDG-PET at diagnoses ≥5.40 (hazard ratio [HR], 1.62; 95 % confidence interval [CI], 1.01-2.61; p = 0.045) and node-positive pathology (HR, 2.01; 95 % CI, 1.32-3.08; p = 0.001) as significant predictors of RFS. Furthermore, the SUVmax at initial diagnosis and after NACRT correlated with liver metastasis. CONCLUSION: R- and BR-PDACs with high SUV on FDG-PET at diagnosis are risk factors for postoperative recurrence. Among patients who undergo surgery after NACRT, those with a high SUVmax at diagnosis or post-NACRT require careful attention for postoperative liver recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalPositron-Emission TomographyNeoplasm Recurrence, LocalNeoadjuvant TherapyChemoradiotherapyHumansMaleFemaleAgedMiddle AgedPancreatectomyRetrospective StudiesAdultAged, 80 and overRadiopharmaceuticals

Stichwörter der Autor:innen

18F-fluorodeoxyglucose-positron emission tomographyNeoadjuvant chemoradiotherapyPancreatic ductal adenocarcinomaPostoperative recurrenceRecurrence-free survival

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan. Electronic address: suto.hironobu@kagawa-u.ac.jp.
  • Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Department of Radiation Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Department of Public Health, Kagawa University, Kagawa, Japan.

Zitieren

APA

Suto, H., Nagao, M., Matsukawa, H., Fuke, T., Ando, Y., Oshima, M., Takahashi, S., Shibata, T., Kamada, H., Kobara, H., Okuyama, H., Hirao, T., Kumamoto, K., & Okano, K. (2024). Relationships between postoperative recurrences and standardized uptake value on 18F-fluorodeoxyglucose-positron emission tomography in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma who underwent curative pancreatic resection after neoadjuvant chemoradiotherapy. Pancreatology. https://doi.org/10.1016/j.pan.2024.08.010

Vancouver

Suto H, Nagao M, Matsukawa H, Fuke T, Ando Y, Oshima M, et al. Relationships between postoperative recurrences and standardized uptake value on 18F-fluorodeoxyglucose-positron emission tomography in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma who underwent curative pancreatic resection after neoadjuvant chemoradiotherapy. Pancreatology. 2024. doi:10.1016/j.pan.2024.08.010

BibTeX
@article{Suto2024,
  author = {Suto, Hironobu and Nagao, Mina and Matsukawa, Hiroyuki and Fuke, Takuro and Ando, Yasuhisa and Oshima, Minoru and Takahashi, Shigeo and Shibata, Toru and Kamada, Hideki and Kobara, Hideki and Okuyama, Hiroyuki and Hirao, Tomohiro and Kumamoto, Kensuke and Okano, Keiichi},
  title = {Relationships between postoperative recurrences and standardized uptake value on 18F-fluorodeoxyglucose-positron emission tomography in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma who underwent curative pancreatic resection after neoadjuvant chemoradiotherapy},
  journal = {Pancreatology},
  year = {2024},
  doi = {10.1016/j.pan.2024.08.010}
}
Kostenlos starten →